参松养心胶囊治疗尿毒症患者失眠89例分析

目的观察参松养心胶囊治疗尿毒症患者失眠的临床疗效。方法将患者89例,随机分为治疗组44例、对照组45例。治疗组口服参松养心胶囊(4粒,3次/d),对照组口服地西泮(2.5mg,1次/晚),疗程均为4周。结果疗程结束后,两组患者的睡眠质量均有提高,治疗组优于对照组(P<0.05)。结论参松养心胶囊治疗尿毒症失眠疗效优于地西泮,且无明显副作用,值得进一步推广。

Objective To investigate the clinical therapeutic effects of Shensongyangxin capsule for insomnia in Uremia Patients. Methods The 89 Uremia cases with insomnia were divided into therapy group（n=33）and control group（n=33）randomly.The patients in therapy group were administrated with Shensongyangxin capsules（t.6g,tid）,while the patients in control group with diazepam （2.5mg,qn）. The treatments Lasted for 4 weeks in both groups. Results After treatment,the two groups patients＇s sleep quality were improved.And the therapy group was better than the control group. Conclusion Shensongyangxin capsules have better effect on insomnia than diazepam in Uremia Patients,and have no obvious side effects. It deserves to be expanded in the clinical application.